Published in Inflammation on August 01, 1990
IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect (2006) 2.39
Pyocycanin, a contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung. PLoS One (2015) 1.39
Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. PLoS Pathog (2006) 1.35
Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol (2002) 1.32
Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect (1992) 1.18
Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax (1995) 1.14
Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect (1999) 0.95
Are women more sensitive than men to 2-propanol and m-xylene vapours? Occup Environ Med (2002) 0.90
Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensis-induced hepatitis in SCID mice. Infect Immun (2008) 0.89
The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol (2002) 0.88
A field study on clinical signs and symptoms in cleaners at floor polish removal and application in a Swedish hospital. Int Arch Occup Environ Health (2010) 0.80
Atopy, symptoms and indoor environmental perceptions, tear film stability, nasal patency and lavage biomarkers in university staff. Int Arch Occup Environ Health (2007) 0.80
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax (1999) 0.79
Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction. Can J Vet Res (2006) 0.78
Neutrophil activation in patients with ASA-induced urticaria. J Clin Immunol (2008) 0.78
Effect of cold-ischemia time on nuclear factor-kappaB activation and inflammatory response in graft after orthotopic liver transplantation in rats. World J Gastroenterol (2004) 0.78
Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury. J Surg Res (2014) 0.77
Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in Sepsis. Mol Med (2015) 0.77
Ocular symptoms, tear film stability, nasal patency, and biomarkers in nasal lavage in indoor painters in relation to emissions from water-based paint. Int Arch Occup Environ Health (2010) 0.77
In vivo suppressive effect of nuclear factor-kappaB inhibitor on neutrophilic inflammation of grafts after orthotopic liver transplantation in rats. World J Gastroenterol (2004) 0.75
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation (1996) 2.91
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol (2001) 2.87
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43
Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature (1986) 2.41
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood (1974) 2.22
Vitamin D deficiency in septic patients at ICU admission is not a mortality predictor. Minerva Anestesiol (2011) 2.19
Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology (1979) 2.14
The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract (1998) 2.11
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
Lipocalins as biochemical markers of disease. Biochim Biophys Acta (2000) 2.08
Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy (2004) 2.03
The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis (1977) 1.95
Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum (1983) 1.78
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73
Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer (1974) 1.73
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med (1999) 1.69
Radioimmunoassay of human eosinophil cationic protein. Br J Haematol (1977) 1.68
Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy (1993) 1.65
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J (1997) 1.65
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med (2000) 1.58
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy (1999) 1.55
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest (1995) 1.51
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
Cross-cultural comparison of depressive symptoms in Europe does not support stereotypes of ageing. Br J Psychiatry (1999) 1.48
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol (1997) 1.47
[Increased sensitivity to pain in long-term opioid treatment]. Nervenarzt (2008) 1.46
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J (1991) 1.45
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med (1996) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy (2001) 1.41
Mechanisms of mitochondria-neurofilament interactions. J Neurosci (2003) 1.41
Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin Exp Allergy (1998) 1.40
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol (1982) 1.40
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg (1995) 1.40
Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med (1997) 1.39
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis (1993) 1.39
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol (1997) 1.37
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl (2002) 1.36
Human eosinophil peroxidase: purification and characterization. J Immunol (1985) 1.36
Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia (2009) 1.33
Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol (1989) 1.32
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med (1999) 1.31
Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res (1985) 1.31
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis Rheum (1982) 1.29
Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest (1975) 1.28
Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest (1976) 1.27
Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther (1996) 1.27
Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol (1977) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest (1994) 1.23
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia (2012) 1.23
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood (1992) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis (1989) 1.21
Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol (1978) 1.19
Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19
Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy (1978) 1.19
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med (2001) 1.18
Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia. Eur J Haematol (1999) 1.17
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol (1988) 1.15
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy (1991) 1.15
Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol (1975) 1.15
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe Seylers Z Physiol Chem (1977) 1.13
Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum. Eur J Clin Invest (1975) 1.13
Interactions between brain mitochondria and cytoskeleton: evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Tech (1994) 1.13
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci (2001) 1.12
Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells. Cell Death Differ (2000) 1.11
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol (1978) 1.11
Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe Seylers Z Physiol Chem (1983) 1.11
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals. Int Arch Occup Environ Health (1999) 1.10
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09
Distribution of antileukoprotease in upper respiratory mucosa. Ann Otol Rhinol Laryngol (1982) 1.09
Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull (1998) 1.08
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08
Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand J Haematol (1972) 1.07
Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07
Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: an initial validation study. Neuropsychology (1999) 1.06